124 results
8-K
EX-99.1
ycm6qkkilak3c zocc
2 Nov 23
Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am
8-K
EX-10.3
9uoe653m1kwwwq11s8r
3 May 21
Departure of Directors or Certain Officers
7:18am
8-K
EX-10.2
2egalnrdzbw
3 May 21
Departure of Directors or Certain Officers
7:18am
8-K
EX-99.1
bawxvb
11 Feb 21
Karyopharm Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Company Progress
7:13am
8-K
EX-99.1
oyv0 bt8b0nufsk4
11 Jan 21
Karyopharm Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Total Revenues and Provides Commercial Update
8:06am
8-K
EX-99.1
z0qxwq0a 71k
18 Dec 20
Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
11:58am
8-K
EX-99.1
81ddx0x75zhv j9ue
2 Nov 20
Karyopharm Reports Third Quarter 2020 Financial Results and Highlights Recent Company Progress
4:11pm